Structural Biology of Non-Ribosomal Peptide Synthetases

Summary

The non-ribosomal peptide synthetases are modular enzymes that catalyze synthesis of important peptide products from a variety of standard and non-proteinogenic amino acid substrates. Within a single module are multiple catalytic domains that are responsible for incorporation of a single residue. After the amino acid is activated and covalently attached to an integrated carrier protein domain, the substrates and intermediates are delivered to neighboring catalytic domains for peptide bond formation or, in some modules, chemical modification. In the final module, the peptide is delivered to a terminal thioesterase domain that catalyzes release of the peptide product. This multi-domain modular architecture raises questions about the structural features that enable this assembly line synthesis in an efficient manner. The structures of the core component domains have been determined and demonstrate insights into the catalytic activity. More recently, multi-domain structures have been determined and are providing clues to the features of these enzyme systems that govern the functional interaction between multiple domains. This chapter describes the structures of NRPS proteins and the strategies that are being used to assist structural studies of these dynamic proteins, including careful consideration of domain boundaries for generation of truncated proteins and the use of mechanism-based inhibitors that trap interactions between the catalytic and carrier protein domains.

1. Introduction

Non-Ribosomal Peptide Synthetases deliver amino acid and peptide intermediates, covalently bound to the pantetheine cofactor of a peptidyl carrier protein, to different catalytic domains where the nascent peptide chain is elongated, modified, and ultimately released [1]. The primary catalytic domains are the adenylation domain that activates and loads the pantetheine thiol group and a condensation domain that catalyzes peptide bond formation. During this latter reaction, the condensation domain catalyzes the transfer of the aminoacyl or peptidyl group from an upstream carrier protein domain to the primary amine of an amino acid that has been previously loaded onto the downstream carrier domain. The final core catalytic domain, present only in the terminal module of an NRPS, is a thioesterase domain that catalyzes either hydrolysis or, more commonly, cyclization of the peptide to catalyze release from the final carrier protein domain.

This modular architecture poses important questions for the mechanisms that allow the synthesis to occur in an efficient manner [2]. Namely, for proper peptide synthesis to occur, it is necessary that each carrier protein domain visit the respective catalytic domains in an organized manner. One could easily see how the delivery of a carrier protein domain to the incorrect adenylation domain or the delivery of an amino acid to a downstream condensation domain rather than the upstream would lead to incorrect peptide products. The NRPSs have therefore attracted the attention of many structural biologists who have determined structures of individual catalytic domains and multi-domain components [3,2]. The cumulative structural understanding is beginning to provide clues to the strategies that NRPS enzymes use to coordinate peptide synthesis. This chapter will first present the structures of NRPS domains and multi-domain complexes (Table I). The fundamental structural mechanism of NRPS enzymes, requiring that the carrier proteins migrate between neighboring catalytic sites, mandates a degree of conformational flexibility in the NRPS systems. We will therefore describe the strategies that have been used to obtain meaningful multi-domain structures that provide insights into the function of these assembly line enzymes.

Table 1.

List of NRPS proteins that have been structurally characterized

PDB	Protein	Ligands/Comments	Ref.
Carrier Protein Domains
1DNY	TycC PCP from 3rd module	Also structures 2GDW, 2GDX, and 2GDY.	[9,6]
4I4D	BlmI	Free-standing (Type II)	[8]
2FQ1	EntB	Fused to isochorismatase domain	[62]
Adenylation Domains
1AMU	Truncated phenylalanine activating domain of GrsA	AMP and phenylalanine	[19]
1MDF	DhbE, free-standing	Also structures 1MD9 (DHB and AMP) and 1MDB (DHB-adenylate)	[20]
3O82	BasE, free-standing	Also structures 3O83, 3O84, 3U16, 3U17, bound to a variety of inhibitors	[30,31]
3ITE	SidN	Eukaryotic NRPS	[63]
Condensation Domains
1L5A	VibH		[43]
4JN3	CDA synthetase	Also 4JN5	[46]
Thioesterase Domains
1JMK	SrfA-C thioesterase		[48]
2CB9	Fengycin Biosynthesis		[49]
Reductase Domains
4DQV	RNRP from M. tuberculosis		[58]
4F6L	AusA Reductase		[59]
Multi-domain NRPS structures
2VSQ	SrfA-C (Cond-Aden-PCP-TE)	Leucine in adenylation domain	[45]
3TEJ	EntF (PCP-TE)	Also 2ROQ (NMR)	[60,61]
2JGP	TycC (PCP-cond domain)		[44]
4IZ6	EntE-B (Aden-PCP)	Mechanism-based inhibitor	[28,29]
4DG9	PA1221 (Aden-PCP)	Mechanism-based inhibitor	[55]
4GR5	SlgN1 (MLP-Aden)	AMPCPP	[38]

2. PCP Domain

Similar to the carrier domains of fatty acid synthesis and metabolism, the NRPS enzymes use a peptidyl carrier protein (PCP) domain that is used to shuttle the substrates and peptide intermediates between different catalytic domains [4]. The PCP domains are the smallest NRPS domains, usually only 70–90 amino acids in length. The PCP domains contain a conserved serine residue that serves as the site for covalent modification with a phosphopantetheine cofactor that is derived from coenzyme A (Figure 1). This post-translational modification converts the apo-carrier protein to a holo- state and is catalyzed by a specific phosphopantetheinyl transferase (PPTase) that is often co-expressed with the NRPS cluster [5]. The thiol of the phosphopantetheine group binds covalently to the amino acid and peptide substrates through a thioester linkage with the carboxyl group of the amino acid.

Figure 1.

Chemical structure of the phosphopantetheine cofactor attached to a conserved serine residue of the peptidyl carrier protein.

Like other acyl carrier proteins, the NRPS PCP domains are composed of four α-helices (Figure 2A). Helices 1, 2, and 4, are longer, and mostly parallel, while the third helix is shorter and runs approximately perpendicular to the axes of the other three. The serine residue that is the site of addition of the phosphopantetheine group is located at the start of helix α2. This helix is preceded by a long loop that is diverse in sequence and structure between the different NRPS PCP domains.

Figure 2.

Structures of core NRPS domains. A. The structure of the Type II PCP domain BlmI (PDB 4I4D). The four helices are shown along with Ser44, the site of phosphopantetheinylation. B. The active site of PheA (PDB 1AMU), the adenylation domain from the gramicidin synthetase NRPS. The ligand molecules AMP and phenylalanine are shown in ball-and-stick represenatation. Protein side chains are labeled including the residues that form the phenylalanine binding pocket and residues that interact with the nucleotide. C. The condensation domain of the CDA synthetase (PDB 4JN3) is shown in ribbon representation. The two subdomains are shown, along with active site residues His156, His157, and Asp161, which is partially obscured by His157. D. The active site of the thioesterase domain from EntF is shown (PDB 3TEJ). The pantetheine, covalently bound to Ser1006, is directed from the PCP domain to the active site, which is composed of the catalytic triad Asp1165, His1271, and Ser1138. The different NRPS domains are shown in specific colors, which will be maintained through the chapter. PCP domains are shown in blue. Adenylation domains are shown in pink for the N-terminal sub-domain and maroon for the C-terminal sub-domain. Condensation domain is shown in light green and the thioesterase domain is shown in yellow.

The NMR structure of the PCP domain from the third module of the TycC NRPS protein of tyrocidin synthesis [6] demonstrated that the NRPS PCP domains share the prototypic fold of the carrier proteins from related modular polyketide and fatty acid synthesis [7]. A recent crystal structures of a free-standing PCP domain [8] confirms the overall fold in an independent carrier domain. Additionally, NMR studies have demonstrated that the core helical structure exhibits dynamic features and the protein adopts multiple conformations in the apo or holo state [9].

As described below, the structures of PCP domains in complexes with catalytic domains demonstrate the regions of the carrier domains that interact with partner proteins. Not surprisingly, given the presence of the phosphopantetheine cofactor at the start of helix α2, this helix and the loop that joins helix α1 to α2 appear to be the primary determinants for interactions with the catalytic domains. Shotgun mutagenesis of the carrier protein of the EntB protein from enterobactin biosynthesis in E. coli followed by screening to test function in vivo identified regions of the PCP that are involved in interactions with catalytic domains. In addition to the loop and helix α2 mentioned above, these studies also identified residues from the short orthogonal helix α3 that also formed part of the hydrophobic patch that governed interactions with the downstream condensation domain [10,11].

3. Adenylation Domain

NRPS Adenylation domains play a key role in peptide natural product biosynthesis. In the assembly line-like choreography, the adenylation domain is the first domain the substrate encounters before it is added to the nascent peptide natural product. The adenylation domains catalyze a two-step reaction that activates the amino acyl substrate as an adenylate, followed by transfer of the amino acid to the thiol of the pantetheine cofactor of the carrier protein domain (Figure 3).

Figure 3.

Reaction catalyzed by the NRPS adenylation domain.

A domains belong to a larger adenylate-forming enzyme superfamily containing Acyl-CoA synthetases, NRPS adenylation domains, and beetle luciferase [12]. These enzymes are structural homologs, and utilize a similar reaction mechanism that is comprised of two half reactions. Structural and kinetic results obtained from acyl-CoA synthetases [13–15] and luciferase enzymes [16,17] have aided in the understanding of the adenylate-forming enzyme family. We focus here specifically on the adenylation domains of NRPS.

NRPS adenylation domains consist of approximately 500 residues. The bulk of the enzyme, residues 1–400, make up the N-terminal subdomain while the final 100 residues form the C-terminal subdomain that sits atop the N-terminal subdomain. Several consensus sequences were identified in adenylation domains and designated A1 through A10 [1,18]. These regions impart both structural and substrate stabilizing roles. The two-step reaction (Figure 3) is carried out in a Bi Uni Uni Bi ping-pong mechanism. First Mg-ATP and the carboxylic acid bind to form an acyl-adenylate. After PP_i from the ATP leaves the active site, a reorganization of the active site occurs where the C-terminal subdomain rotates changing the active site for the second half reaction. This domain alternation strategy transitions the adenylation domain between the two half reaction conformations, adenylate-forming and thioester-forming [12].

The first two structures of NRPS adenylation domains were PheA (Figure 2B), a phenylalanine activating adenylation domain dissected from the multi-domain gramicidin synthetase 1, and the free-standing 2,3-dihydroxbenzoic acid (DHB) specific DhbE [19,20]. Both of these structures are in the adenylate-forming conformation with Phe and AMP in the active site of PheA and no substrate, a DHB-adenylate, and DHB and AMP in the active site of the three DhbE structures. While the bulk of the active site is located in the N-terminal subdomain, a Lys found on the A10 loop of the C-terminal subdomain is required for acyl-adenylate formation [21,22]. In both PheA and DhbE the Lys is poised in the active site to interact with both the carboxylic acid and the phosphate of the AMP (Figure 2B). Important N-terminal regions to note are: the phosphate-loop (A3) that orients the β and γ phosphates of ATP and is often unresolved when ATP is not in the active site demonstrating its flexibility, the aromatic residue of the A4 motif (Phe234 in PheA and His207 is DhbE) which interacts with the carboxylic acid, and the aspartic acid of A7 motif that interacts with the ATP ribose hydroxyls. Once the high-energy acyl-adenylate is formed and PP_i leaves the active site, domain alternation occurs to prepare the active site for the thioester-forming reaction.

The determination of a related acyl-CoA synthetase [13] provided the first view of a distinct catalytic conformation of a member of this adenylate-forming family. Compared with the previous structures of PheA and DhbE, the C-terminal subdomain of bacterial acetyl-CoA synthetase (Acs) was rotated by ~140° to a new position that created a binding pocket for the CoA nucleotide and a tunnel through which the pantetheine thiol approaches the adenylate of the active site. The hypothesis that all members of this family adopt both catalytic conformations, an adenylate-forming conformation as seen in PheA and a thioester-forming conformation seen in Acs, has now been thoroughly tested. In particular, extensive structural and biochemical analyses with Acs [13,22] and the related protein 4-chlorobenzoyl-CoA ligase [23,14,15,24] have demonstrated the specific involvement of residues on opposite faces of the C-terminal domain in catalyzing the respective partial reactions.

The 140° domain alternation occurs around a conserved hinge residue, an Asp or a Lys, located in the A8 motif. The importance of the hinge residue and its ability to change rotamers was demonstrated when the hinge in 4-chlorobenzoyl-CoA ligase was mutated to a Pro which essentially trapped it in the adenylate forming conformation [22,15]. Domain alternation changes the active site without moving the substrate. Notably, the A10 catalytic Lys is removed from the active site by ~25 Å. Also the A8 loop interacts with the N-terminal subdomain where PP_i exited and hydrogen bonds with the aromatic residue of the A4 motif rotating it away from the adenylate. This makes room for the pantetheine thiol to attack the carboxylic carbon thus displacing AMP and loading the pantetheine arm of the PCP with the amino acid substrate.

Another model protein that is closely related to NRPS adenylation domains offers more evidence for the role of the rotation of the C-terminal sub-domain. The DltA protein from B. subtilis is involved in cell wall biosynthesis, where it activates a molecule of L-Ala and loads into onto the partner carrier protein DltC. Thus, while not strictly an NRPS adenylation domain, the protein is highly homologous and serves as a useful model for understanding NRPS adenylation domains. The structures of the DltA have been solved with AMP [25] and Mg-ATP [26] in the active site and illustrate the distinct adenylate- and thioester-forming conformations.

In addition to DhbE, many additional bacterial siderophores derived from NRPS systems contain a salicylate or 2,3-dihydroxybenzoate moiety that is involved in iron binding [27]. Often, the aryl acid is activated by an independent adenylation domain. The structures of the E. coli homolog EntE [28,29], as part of an adenylation-PCP complex, and A. baumannii BasE [30,31] have also been solved. While DhbE adopts the adenylate-forming conformation, EntE adopts the thioester-forming conformation (Figure 4). BasE, like several other adenylation domains, shows no electron density for the C-terminal sub-domain, suggesting it is adopting multiple conformations in the crystal lattice.

Figure 4.

Domain alternation of NRPS adenylation domains. The structures of two free-standing adenylation domains are shown from two bacterial siderophore synthesis, A. DhbE from the bacillibactin NRPS of B. subtilis and B. EntE from the enterobactin NRPS of E. coli. The DhbE structure (PDB 1MDB) is in the adenlyate-forming conformation, with the A10 motif of the C-terminal subdomain directed towards the active site. The EntE structure (PDB 4IZ6) adopts the thioester-forming conformation with the A8 motif near the active site. The carrier protein and the pantetheine cofactor of structure 4IZ6 are not shown for clarity.

Many NRPS clusters contain a small ~70 residue protein that plays a role in activation of the adenylation activity [32]. The first characterized protein was encoded by the mbtH gene of M. tuberculosis and these proteins are therefore known as MbtH-Like Proteins (MLPs). Biochemical evidence has demonstrated that some adenylation domains require the MLPs for acyl-adenylate formation [33–35]. To date three MLP structures are available: the founding member MbtH, PA2412, and SlgN1 [36–38]. MLPs are thin arrowhead-shaped proteins with three central anti-parallel β-sheets followed by two α-helices [37]. Defined in the MLP consensus sequence [32] and presented on one side of the MLP are two Trp residues that stack against each other. These Trp residues were shown to be required for activation of the the adenyaltion domain by MLP [39]. A series of conserved proline residues have also been tested and appear to not be essential for activation of the adenylation domain [40]. A clear understanding of the mechanisms by which MLPs activate the adenylation domains is currently unknown.

4. Condensation Domain

Condensation domains, usually located at the N-terminus of a module, catalyze amide bond formation between two substrates. The condensation domains transfer the amino acid or peptide from an upstream carrier protein domain to the amino moiety of the substrate that has been previously loaded onto a downstream carrier protein domain (Figure 5).

Figure 5.

Reaction catalyzed by the NRPS condensation domain.

These 450 residue domains belong to the chloramphenicol acetyltransferase (CAT) superfamily. Similar to CAT, condensation domains contain a conserved HHxxxDG motif [1]. In CAT, the second His of this motif acts a general base that extracts a proton from chloramphenicol promoting nucleophilic attack and thus acyl transfer [41]. This His is also essential for condensation domain activity [42]; however, its exact role may depend on the substrates [43,44]. Currently there are four crystal structures of condensation domains. They are: the standalone condensation domain VibH [43], the final condensation domain and its donor PCP dissected from the multi modular TycC [44], the condensation domain in the terminal module SrfA-C solved as a complete module [45], and finally the first condensation domain dissected from Calcium-Dependent Antibiotic synthetase (CDA-C1) [46].

Most commonly, a condensation domain will bind to an upstream donor and an downstream acceptor PCP. In some cases, especially with condensation starter domains, a substrate not bound to a PCP may be used. For example the standalone condensation domain VibH uses norspermidine as the acceptor which accepts DHB from the pantetheine arm of VibB [43]. Despite the current condensation domain structures lacking native ligands in the active site, much can be inferred from the current structures (Figure 2C). While CAT forms a cyclic trimer [41], the monomeric condensation domains form a pseudo-dimer composed of two subdomains that contain CAT-like folds. The two subdomains adopt a V-shaped structure with a central cleft; at the base of this cleft, the two subdomains are linked by an α-helical linker. Also just above the linker between the two subdomains is the active site with the second His in the HHxxxDG motif located on a portion of the C-terminal subdomain that crosses over to the N-terminal subdomain. A second loop that spans the cleft between the two subdomains has been referred to as a lid or a latch. Despite the name, there is no evidence that this latch opens and closes [46]. Between these two cross-overs, a tunnel is formed. As the PCPs bind to the condensation domain, their pantetheine arms must reach through this tunnel to the HHxxxDG active site in order for peptide bond formation to occur.

TycC and SrfA-C are both multi-domain structures each with a condensation domain that natively binds two PCPs. The TycC structure has an upstream donor PCP attached via a short linker. While the two domains are interacting, it does not appear that this is the catalytically active state. The Ser on the PCP which the pantetheine is loaded onto is 46.5 Å from the HHxxxDG motif, however the pantetheine is only ~16 Å long. Also several residues on the PCP that have been shown to be required for PCP-C domain interaction [47] are not involved in the interactions found in TycC. On the other hand, SrfA-C, as described below, does appear to form a valid domain interaction despite the pantetheine accepting Ser of the PCP being mutated to an Ala thus making SrfA-C catalytically dead. This mutated residue is located ~16 Å from the HHxxxDG motif. Also the PCP residues required for PCP-C interactions are interacting with the condensation domain. Specifically, the PCP residues Met1007 and Phe1027 form hydrophobic interactions with Phe24 and Leu28 of the condensation domain [45].

The CDA-C1 structure [46] is the most recent condensation domain structure solved and provides a unique insight into the possible dynamics of NRPS condensation domains. CDA-C1 is in a distinctly more closed conformation than any of the other three condensation domains. In the CDA-C1 structure the N-terminal subdomain is 15°, 22°, and 25° more closed than VibH, TycC and SrfA-C respectively. Both SAXS and biochemical data suggest that this closed conformation seen in CDA-C1 is not due to crystal packing and is biochemically active [46]. Furthermore, normal mode analysis, morphing with energy minimization, and molecular dynamics all confirm that this opening and closing is possible. It is plausible however that condensation domains do not undergo this dynamic motion and are instead locked into a more opened or closed conformation based on the size of the substrate they need to accommodate and thus their location in the NRPS biosynthetic pathway. This however does not appear to be the case as SrfA-C is in a more opened conformation than TycC despite TycC being located on the ninth module of the system and SrfA-C being located on the seventh. More work is needed to fully understand the dynamics of condensation domains. Also since all current condensation domain structures lack ligands in the active site it is unclear how terminal condensation domain accommodate such large peptide substrates.

5. Thioesterase Domain

Within the final module of an NRPS pathway, the activity of the final condensation domain catalyzes the transfer of the upstream peptide to the amino acid substrate that is loaded onto the terminal PCP domain. To release the peptide and free the NRPS enzyme for another round of synthesis, the activity of a thioesterase domain is required (Figure 6).

Figure 6.

Reaction catalyzed by the NRPS thioesterase domain.

The thioesterase domains are approximately 30 kD in size and, as a class, can function as either hydrolases (as shown in Figure 6) or as cyclases, where they can catalyze either lactam or lactone formation with an upstream heteroatom from the peptide chain. The thioesterase domains form an acyl-enzyme intermediate with an active site serine residue that subsequently is released from the enzyme through either hydrolysis with a water nucleophile or cyclization. For enzymes that catalyze lactone or lactam formation, the active site pocket therefore must bind the peptide substrate in an orientation that favors cyclization over hydrolysis by positioning the nucleophilic group to resolve the acyl-enzyme intermediate.

Structures of the genetically truncated thioesterase domains from the SrfA-C subunit [48] of the surfactin NRPS cluster and the FenB protein [49] of the fengycin cluster have been determined. The structure of the thioesterase domain from SrfA-C (Srf-TE) showed the domain belongs to the family of α/β hydrolases composed of a central, mostly parallel β-sheet that is surrounded by α-helices. Srf-TE contains a catalytic serine residue that serves as a nucleophile, attacking the terminal carbonyl of the peptidyl thioester with the pantetheine on the terminal PCP (Figure 2D).

Three helices form a lid that in Srf-TE adopts two different conformations in the two molecules of the asymmetric unit, referred to as open and closed. The closed state is suggested to be a ground state of the enzyme however the helices in this state also exhibit some degree of disorder. Surfactin, the product of the Srf NRPS system, is an acyl-heptapeptide that contains 7 amino acids and an N-terminal β-hydroxy fatty acid. The molecule cyclizes via lactone formation between the C-terminal carboxylate and this β-hydroxyl moiety. The authors soaked an N-acylheptapeptide-N-acetylcysteamine analog lacking the β-hydroxyl into the crystal. Portions of this molecule could be observed in the active site pocket, although the density was not of sufficient quality to enable complete modeling. The density did demonstrate a bent configuration that suggested the contour of the active site directs the cyclization reaction [48].

The thioesterase domain of the fengyncin FenB protein (Fen-TE) has also been structurally characterized [49]. Like Srf-TE, Fen-TE was also genetically truncated to enable crystallization of the thioesterase domain. Fengycin is a acyl decapeptide lactone that contains a tyrosine at the fourth position that cyclizes through the phenolic hydroxyl with the C-terminal carboxylate of the peptide. To further characterize the active site, the structure of the enzyme covalently acylated with phenylmethylsulfonyl fluoride, the common inhibitor of hydrolases and proteases containing a serine nucleophile, was determined. The phenyl group from the inhibitor bound in a pocket that likely is used by the last Leu residue of the fengycin peptide. An oxyanion hole that stabilizes the generation and cleavage of the acyl-enzyme intermediate is formed by the backbone amides and is conserved throughout the α/β-hydrolase family. A molecule of fengycin was modeled into the substrate binding pocket and examined with molecular dynamics that showed no dissociation and limited movement of the ligand after an initial equilibration period [49]. This supported the position derived from docking and identified residues that could form interactions with the peptide ligand. In particular, the Tyr hydroxyl from the fourth position of the fengycin peptide was directed through a hydrophobic ridge to a position that allowed attack on the acyl-enzyme intermediate for the cyclization portion of the reaction.

6. Additional Integrated Domains

Additional protein activities are used in NRPS pathways for the complete synthesis of the final product. These proteins often act upon the substrate precursors prior to incorporation into the NRPS assembly line or on the immature peptide in steps that result in the final product maturation [50]. Certain auxiliary proteins do catalyze reactions on the amino acyl or peptidyl intermediates that are bound to a carrier protein. Most of these domains are expressed from isolated genes and most function as independent single domain proteins. However, some proteins are integrated into the NRPS assembly line where they are co-expressed. The most common of these are epimerization and methylation domains, as well as the alternate termination domains that thioester cleavage via an NAD(P)H-dependent reduction.

6.1. Epimerization domains

Two different types of epimerization domains have been identified in NRPS systems where they catalyze conversion of L-amino acids to D-amino acids. Canonical epimerization domains of ~450 residues are inserted between PCP and condensation domains. While several systems, notably the PchE protein of pyochelin biosynthesis [51] and the HMWP2 protein of yersiniabactin biosynthesis [52], have a shorter, ~350 residue, non-canonical epimerization domain.

Interestingly, the canonical epimerization domains show sequence and structural homology to condensation domains. Only a single structure exists of an NRPS epimerization domain of the epimerization domain from tyrocidin synthetase A [53]. The structures displays the same overall symmetrical fold as the condensation domains, with a large cavity in the center of two subdomains. The epimerization domain contains the same conserved HHxxxDG motif present in the condensation domains. Mutation of the second histidine (His753) and the aspartic acid (Asp757) of this motif, as well as several downstream residues including a glutamate at position 892 and a conserved asparagine and tyrosine pair 975 and 976, were defective for proton wash-out in the epimerization domain of the first module of the gramicidin synthetase, GrsA [54]. In the structure of the TycA epimerization domain, these histidine and the glutamate residues, His743 and Glu882, are positioned on opposite sides of the active site cavity and are potential candidates for a two-base epimerization reaction. The glutamate is part of a conserved EGHGRE motif that is common to epimerization domains, but not the homologous condensation domains [1].

The non-canonical epimerization domains are present in the pyochelin producing NRPS, protein PchE of P. aeruginosa and Burkholderia pseudomallei. It shares the interesting property with N-methylation domains of being inserted within the C-terminal sub-domain of the NRPS adenylation domain. There is no structural information regarding these epimerization domains, nor is there any information how the adenylation domain accommodates these insertions.

6.2. N-Methylation Domains

N-methylation of the peptides of NRPS products is seen primarily in fungal NRPS systems. Presumably, this confers proteolytic stability to the methylated peptide bonds. Like the non-canonical epimerization domains, the N-methylation domains are inserted into the C-terminal subdomain of the NRPS adenylation domains. The methylation domain is ~420 residues in length and shows limited homology with other S-adenosylmethionine dependent transferase enzymes. The C-terminal subdomain of the NRPS adenylation domain contains a central three-stranded β-sheet that contains two long anti-parallel strands that each range in length from 7 to 11 residues. Following these two strands is a loop that leads to an amphipathic helix that packs against the central β-sheet. It is into this large loop that the N-methylation domains are inserted. In the structure of the complex between the adenylation and the PCP [55,28,29], this loop from the adenylation C-terminal subdomain is directed towards the PCP, suggesting that perhaps the amino acid substrate could be directed to the neighboring methyl transferase domain without a major structural rearrangement of the catalytic domains.

There are no reported structures of NRPS methyl transferase domains. A comparison with the Protein Data Bank finds only short stretches of homology (80–100 residues) to related SAM-dependent methyltransferases, for example the NodS protein of Bradyrhizobium japonicum [56]. Additionally, the structure of a SAM dependent N-methyltransferase from the glycopeptide NRPS cluster of Amycolatopsis orientalis has been determined [57] however this protein is an independent tailoring enzyme with limited homology to the integrated methyl transferase domains of NRPSs.

6.3. Reductase Domains

Certain NRPS clusters terminate not with a thioesterase domain but rather with a NAD(P)H-dependent reductase domain that cleaves the bound peptide to release a C-terminal alcohol or aldehyde rather than a carboxylate. The ~280 residue reductase domains show homology to nucleotide cofactor binding short-chain dehydrogenase/reductase (SDR) enzymes. The structure of a reductase domain from a functionally uncharacterized NRPS protein from Mycobacterium tuberculosis (designated R_NRP) was determined to confirm the expected Rossmann fold common to SDR enzymes [58]. A small helical C-terminal domain was identified as well as a short helix-turn-helix insertion in the standard Rossmann fold. Although the structure of a liganded reductase domain was not obtained, examination of cofactor binding by small-angle X-ray scattering identified a small change in the radius of gyration of the domain, suggesting a conformational transition from an open to a closed state. A second structure of the aldehyde-producing reductase domain of AusA, catalyzing therefore only a 2 e⁻ reduction rather than the sequential 4 e⁻ reduction of R_NRP, has also been structurally characterized showing a similar overall structure [59]. A di-domain construct, composed of the carrier protein and reductase domain was also crystallized; however, no electron density for the carrier protein domain was observed in this structure preventing insights into the nature of the interaction between the catalytic and carrier domains.

7. Multi-Domain NRPS Crystal Structures

Due to the plasticity of NRPSs, crystal structures of multi-domain constructs are difficult to obtain. Similarly, the large size of these proteins presents challenges for NMR. Despite these difficulties there are currently five multi-domain NRPS structures that are in or appear to be in a catalytically relevant state. They are: the four-domain module of SrfA-C [45], the PCP-thioesterase domains of EntF [60,61], the chimeric adenylation-Carrier Protein EntE-B [28,29], the native adenylation-PCP protein PA1221 [55], and the MLP-adenylation domain SlgN1 [38]. As noted earlier, the structure of the excised PCP-condensation domain from TycC has been determined [44]; however, the two domains do not appear to interact in a functional manner. These crystal structures help to shed light on how the domains of NRPSs interact to carry out natural product biosynthesis.

7.1 SrfA-C, a complete NRPS module

SrfA-C is the largest NRPS crystal structure to date and offers a complete view of an NRPS module. Composed of a domain architecture of condensation-adenylation-PCP-thioesterase, the 144 kDa SrfA-C is the terminal module from the surfactin biosynthetic cluster of Bacillus subtilis [45]. In order to crystallize SrfA-C the Ser of the PCP that is pantetheinelated was mutated to an Ala to produce a homogenous protein sample. Nonetheless, the PCP is interacting with the condensation domain in a catalytically relevant way (Figure 7A). The condensation and N-terminal subdomain of the adenylation domain share a large interdomain interface and are believed to form a stable platform, upon which the PCP is thought to migrate between different catalytic domains. The C-terminal subdomain of the adenylation domain is neither in the adenylate or thioester-forming conformations. Instead it has adopted an intermediate conformation that is closest to the adenylate forming conformation. Because of this intermediate conformation the catalytic Lys on the A10 motif is positioned slightly outside of the active site, which may prevent the adenylation domain from activating another substrate before the PCP is ready to accept it. The thioesterase domain is positioned near the condensation domain and, interestingly, the pantetheine channel on the thioesterase is facing directly into the core of the SrfA-C protein. A simple rotation of the PCP is therefore insufficient to allow a functional interaction between the PCP and thioesterase domains. This is evident from aligning SrfA-C with the EntF PCP-thioesterase structure [60,61]. It therefore seems that rotation of the thioesterase domain relative to the core of the SrfA-C module is necessary to adopt a catalytic conformation.

Figure 7.

Crystal Structures of multi-domain NRPS proteins. A. The structure of the complete termination module of SrfA-C (PDB 2VSQ) shows the PCP interactions with the downstream side of the condensation domain. B. The adenylation-PCP structure of PA1221 (PDB 4DG9) illustrates a functional interface between the PCP and the thioester-forming conformation of the adenylation domain. C. The structure of the SlgN1 protein (PDB 4GN5) shows the interaction between the MbtH-like domain (forest green) interacting with the N-terminal subdomain of the adenylation domain. The conserved tryptophan residues are highlighted in the MLP. D. The PCP-thioesterase domain of EntF (PDB 3TEJ) is shown illustrating the binding of the pantetheine into the active site of the thioesterase domain.

7.2 EntE-B and PA1221, Adenylation-Carrier Protein complexes

The structures of the adenylation-carrier protein complexes of the chimeric EntE-B and the native PA1221 (Figure 7B) were solved in the thioester-forming conformation with the use of aryl/acyl-adenosine vinylsulfonamides [55,28,29]. In both structures, the carrier protein is interacting with the adenylation domain and the pantetheine is positioned in the adenylation domain tunnel forming a covalent bond with the adenosine inhibitors. The chimeric EntE-B, which was genetically combined using a linker of similar sequence length and composition to multi-domain NRPSs, formed a domain swapped dimer where the carrier protein from molecule 1 was interacting with the adenylation domain of molecule 2 and vice versa. A comparison to SrfA-C suggests that while the EntE-B linker was of similar sequence length as SrfA-C, the EntE-B linker formed an α-helix which rendered the linker too short for an intra-molecular interaction.

Both the EntE-B and PA1221 structures reveal the various interactions between the adenylation and carrier protein domains which includes both hydrophobic interactions and hydrogen bonding [28]. Biochemical studies also help to confirm that while the EntE-B forms a domain swapped dimer due most likely to the linker, the interaction between the ArCP and the A domain seem to be the same interaction that would occur in the intra-domain interaction. In particular, the insights derived from the EntE-B crystal structure were used to guide mutations in the EntE homolog from A. baumannii to improve the ability to recognize the heterologous EntB carrier protein as a partner [29].

7.3 SlgN1, An MLP-Adenylation Domain Structure

As noted earlier, some adenylation domains require MLPs for acyl adenylate formation [32,34,35,33]. The crystal structure of SlgN1, containing a MLP fused to the N-terminus of an adenylation domain, showed for the first time were MLPs bind to adenylation domains [38]. The MLP binds the N-terminal subdomain of the adenylation domain distal from the active site (Figure 7C). The closest active site motif appears to be A7 aspartic acid which binds the ribose hydroxyls of the ATP. A key interaction is an Ala residue presented on the surface of SlgN1 that is inserted between two stacked Trp on the MLP. For MLP dependent adenylation domain this Ala (Ala 433 in SlgN1) is highly conserved while for non-dependent MLP adenylation domains this residue varies. Unfortunately the C-terminal subdomain of the adenylation domain of SlgN1 was removed to facilitate crystallization. Therefore it is unclear if the MLP is bound to the adenylation domain for just acyl adenylate formation or also for the subsequent thioester formation.

7.4 EntF, PCP-Thioesterase Domain Structures

Finally, the structures of the PCP-TE domains of EntF were solved by both x-ray diffraction and NMR [60,61]. While the NMR structure was that of an apo PCP and shows a dynamic interaction, the crystal structure used an α-chloroacetyl amide coenzyme A analog which was loaded onto the PCP domain using the phosphopantetheinyl transferase Sfp. This made it possible to structurally analyze the thioesterase pantetheine channel along with the domain interactions (Figure 7D). The pantetheine is inserted into the thioesterase channel which complements the pantetheine with a hydrophobic pocket around the di-methyls of the pantetheine, hydrogen bonding with the two amide carbonyls, and also van der Waals interactions [61]. At the end of the channel the loaded pantetheine encounters the thioesterase catalytic triad. The PCP and thioesterase form extended hydrophobic interactions which includes the thioesterase lid region which interacts with the PCP.

7.5 Modeling of Dynamics of the SrfA-C Module

While only a few structures of multi-domain NRPSs exist, the various conformations available assist in decoding the NRPS choreography for natural product biosynthesis. In order for substrate loading onto the pantetheinelated PCP the adenylation domain undergoes domain alternation after activating the substrate. Now in the thioester-forming conformation the PCP can interact with the adenylation domain and the pantetheine can enter the adenylation domain tunnel and attack the substrate (Figure 8A). With the substrate loaded the PCP can now migrate over to the condensation domain where it awaits the delivery of the upstream peptide or amino acid substrate (Figure 8B). Based on the SrfA-C structure it appears that A domain needs to adopt or come close to adopting the adenylate-forming conformation. It seems plausible that the movement of the C-terminal subdomain of the adenylation domain facilitates the movement of the PCP between the adenylation and condensation domains. The C-terminal subdomain and the PCP do not move as a rigid body; rather there appears to be two components to the movement to allow the PCP to adopt the proper position bound to the adenylation domain [55]. Finally the PCP must interact with the thioesterase domain. Since the thioesterase active site channel is directed toward the core of the condensation domain, the PCP and thioesterase domains must move relative to the condensation and adenylation domains, as also relative to each other, to allow a functional interaction to form.

Figure 8.

Model for the delivery of the PCP to the adenylation domain active site. The SrfA-C protein is shown in A. A model conformation that adopts the thioester-forming conformation where the PCP is bound to the adenylation domain and B. the crystallographic structure where the PCP interacts with the condensation domain. The N-terminal subdomain of the adenylation domain, as well as the condensation and thioesterase domains, are all shown in surface representation, while the PCP and the C-terminal subdomain of the adenlyation domain are shown as ribbons. The structure in panel A is derived by modeling the SrfA-C (PDB 2VSQ) adenylation and PCP domains onto the thioester-forming conformation observed with EntE-B (PDB 4IZ6) or PA1221 (PDB 4DG9). The serine residue that is the site of phosphopantetheinylation is highlighted with the yellow sphere.

8. Strategies to Crystallize NRPS Proteins

Structurally characterizing NRPS proteins through either NMR or X-ray crystallography is challenging given that a complete module is over 1000 residues in length and multi-domain proteins containing multiple modules are not uncommon. The large size limits the use of NMR and the size and flexibility make crystallization anything but routine. Despite these challenges, the previous sections have described numerous successful examples of structural characterization of the NRPS proteins. We present here a summary of the strategies that have been used to overcome the difficulties inherent to these large modular proteins.

8.1 Structural Studies of Individual Domains

Examination of single domains can provide insights into the action of multi-domain proteins. Initial attempts at structural characterization of NRPSs therefore focused on individual domains; only more recently have multi-domain structures been achieved. These early studies took advantage of both the rare type II nature of some NRPS clusters, where individual catalytic domains were expressed as a single domain protein, as well as the use of molecular tools to produce genetically truncated proteins.

Specific examples of the study of type II NRPS domains include the VibH condensation domain [43] and the DltA [25] and BasE [30] adenylation domains. Insights into the carrier domain architecture resulted from the type II PCP domain that has recently been determined [8], as well as the full length structure of EntB, a two-domain protein that contains a catalytic isochorismatase domain fused to a carrier protein domain [62]. Comparison of these structures with truncated and multi-domain proteins have failed to demonstrate any features that differ between the type I and type II protein domains.

Type II NRPS proteins are relatively rare, however, and most studies of single NRPS domains have used genetically truncated protein constructs. The production of isolated domains presents additional challenges as it is necessary to identify accurately the domain termini. A truncation that is too short can result in exposure of hydrophobic residues that normally reside within the protein core. Alternately, defining a domain boundary that is too large may result in the inclusion of linker sequences or portions of neighboring domains that are poorly ordered. Often, these extraneous regions can hinder protein folding or solubility and preclude functional or structural analysis. Likely for this reason, many of the genetically truncated NRPS domains that have been studied lie at the N- or the C-terminus of the native multi-domain protein. Indeed, of the many NRPS proteins that have been structurally characterized (Table 1), only three truncated proteins are truly “internal”, where a choice needed to be made about the precise locations of both the N- and C-terminal truncations. Two structural studies on the TycC protein from tyrocidin synthesis, describing the PCP domain from the third module [9,6] and the PCP-condensation didomain crystal structure [44], were internal domain constructs. Additionally, an adenylation domain from SidN [63], a protein that is involved in the production of a fungal siderophore [64], was also excised from the middle of a larger NRPS protein. In this last example, the authors note that successful structure determination of SidN required optimization of the N- and C-termini and that changes of as few as 14 residues could impact protein solubility.

The choice of the boundaries between domains is therefore a critical decision to be made in expression of a genetically-truncated NRPS domain. The availability of existing structures provides useful clues to guide the design of a protetin construct. Identification of the boundary between the adenylation and PCP domains is aided by the presence of a conserved A10 catalytic motif near the C-terminus of the adenylation domain. This nearly identical motif is defined as PXXXXGK, where the X can represent any amino acid [12,1]. Following this motif is a loop that leads to the start of helix 1 for the downstream PCP domain. In both the structures of SrfA-C and PA1221, the natural NRPS protein structures showing the adenylation-PCP linker, the 9 residues following the catalytic lysine pack against the C-terminal domain. In the structure of the PheA genetically truncated adenylation domain, the 11 residues following the A10 lysine interact with the body of the C-terminal subdomain. Therefore, at least 10 residues following the A10 lysine should be considered to be part of the adenylation domain and should not be disrupted through a genetic truncation.

Not including the type II PCP domain [8], which has a longer N- and C-termini, the PCP domains are fairly consistent in size. The type I PCP domain structures, whether in isolation or as part of the multi-domain targets, all have 29–32 residues between the start of the helix α1 and the serine that is phosphopantetheinylated. This defines the N-terminal region of the PCPs that should not be disrupted. Similarly, the distance from the site of cofactor modification to the C-terminal end of helix α4 in the type I PCP domains is 37 or 38 residues in all but PA1221, which is slightly longer at 40 residues. This again defines the boundaries of the PCP fairly consistently.

The definition of the start of the condensation domains is more challenging, given that three of the four available structures are derived from protein domains that lie at the N-terminus of the protein. The shortest N-terminus comes from VibH, the self-standing condensation domain of vibriobactin biosynthesis [43]. An α-helix is the first secondary structural element that is shared by all four. While the VibH structure begins two residues before this helix, the remaining three structures share an additional six residues that should likely be maintained in a condensation domain.

To define the C-terminus of the condensation domain, the SrfA-C structure offers the best view of the linker between the condensation and adenylation domains. This linker, composed of 32 residues, interacts closely with residues from both domains. The first 13 residue interact with the condensation domain, while the remaining helix and loop interact with the adenylation domain. The tighter interaction between the linker and both catalytic domains relates to the fact that the condensation and N-terminal subdomain of the adenylation domain are expected to form a stable interface that likely does not change during the NRPS catalytic cycle.

The thioesterase domain, by definition, resides at the C-terminus of the NRPS protein so the C-terminal end will be defined. The thioesterase domains are nearly always preceded by a PCP domain and the boundary of the PCP is defined, as discussed above. This leaves a short loop, as is seen in the PCP-thioesterase structure that is a suitable site for truncation to produce an isolated thioesterase domain.

8.2. Mutations to the phosphopantetheinylation site

Crystallization requires a uniform protein sample that is suitable to form the crystal lattice. One source of heterogeneity in NRPS proteins derives from the PCP domain and their mixture of apo- and holo- proteins that bear the phosphopantetheine modification. The preparation of holo-PCP domains use either co-expression of a phosphopantetheinyl transferase or biochemical incubation with a specific or general PPTase. While these reactions should proceed to completion, there are no good ways to separate the apo- from holo-PCP domains. Therefore, several structural studies, by both NMR and crystallography, have used mutated PCP domains in which the serine residue is replaced with an alanine. This mutation dictates that the apo-protein is present at 100% and limits heterogeneity. Of course, there are certain limitations to this strategy as the apo- protein is not the biologically active form of the PCP domain. The differences in overall structure of the TycC PCP domain that depend on the apo- and holo- state of the protein [9] should therefore be considered if this apo-PCP domain is used.

Nonetheless, the mutation of the serine to an alanine removes the potential for modification by the PPTase enzymes and prevents the presence of the flexible cofactor that may hinder crystallization. This strategy has been used in the crystallization of the SrfA-C module [45] and also in the investigation of the solution structure of the PCP-thioesterase domain [60].

8.3. Use of selective inhibitors to minimize conformational flexibility

The use of specific ligands that bind in the active sites of NRPS domains to reduce the conformational dynamics has proven to be quite useful and additionally provides some of the most detailed views of ligands bound in the active sites of NRPS domains. The most effective of these inhibitors are mechanism-based inhibitors that mimic intermediates in the reaction pathway and therefore provide the added benefit of demonstrating how the catalytic domains recognize their substrates. Additionally, these compounds have been useful to trap the transient interactions between catalytic and carrier protein domains.

The first example of such a compound was the use of a chloroacetyl thioester of the pantetheine cofactor that was used by Bruner and Liu to crystallize a PCP-thioesterase complex (Figure 9A). An α-chloroacetyl amide derivative of amino-CoA, where the CoA terminal thiol is replaced with an amine was generated [65]. This modified CoA molecule was loaded onto the PCP domain via a PPTase and shown to inhibit the thioesterase reaction. The proper binding of the α-chloroacetyl moiety in the proximity of the nucleophilic serine of the thioesterase domain was proposed to facilitate the interaction between the PCP and thioesterase domains [65]. Subsequently, this inhibitor was indeed used as a tool to crystallize the di-domain PCP-thioesterase of EntF [61]. Although designed to form a covalent interaction between the panthetheine and the catalytic serine of the thioesterase domain by attack on the α-carbon [65], the inhibitor molecule in the active site was not covalently attached to the protein. The authors proposed a mechanism whereby the Ser1138 attacked the carbonyl carbon of the α-chloroacetyl amide pantetheine derivative to form an oxyanion that displaces the chloride ion and forms an epoxide intermediate. This was then hydrolyzed either directly or following reaction with another nucleophilic group on the enzyme.

Figure 9.

Mechanism-based inhibitors used to crystallize NRPS multi-domain structures. A. The α-chloroacetyl-CoA derivative was designed to react with the catalytic serine of thioesterase domain. The catalytic reaction, the inhibitor rationale, and the observed structure are shown. B. The vinylsulfonamide inhibitor is shown, along with the two-step reaction catalyzed by the adenylation domain. The covalent inhibitor complex has been observed in two crystal structures.

A second strategy to use mechanism-based inhibitors has been used successfully to determine the structure of the interaction between adenylation and PCP domains. This strategy expanded upon the use of sulfonamide inhibitors of the adenylation domain in which the phosphate diester moiety of the acyl adenylate intermediate was replaced with sulfamate or sulfamide analogs [66–68]. To further optimize this inhibitor to react covalently with the pantetheine thiol of a partner carrier protein domain, Aldrich and colleagues introduced a linker containing a double bond between the sulfonamide moiety and the salicylic acid (Figure 9B) on an inhibitor directed towards the aryl-activating type II adenylating enzyme MbtA [69]. The affinity of this vinylsulfonamide inhibitor is reduced by nearly 5 orders of magnitude with MbtA compared to the parental sulfonamide inhibitor [70], likely due to the loss of the carbonyl carbon and the nitrogen atom of the linker [69]. However it still displayed apparent inhibition constants of 100–300 µM against the adenylation reaction and was deemed sufficient for biochemical and structural studies. Additionally, in the presence of the adenylating enzyme MbtA, the vinylsulfonamide inhibitor reacted covalently with the pantetheine moiety of the MbtB carrier protein and the adenylation and PCP proteins co-migrated on a native gel.

Suitable vinylsulfonamide analogs of adenylate intermediates have been used to trap crystallographically proteins from two different NRPS systems. It was first used to determine the structure of the adenylation-PCP interface between the EntE adenylation domain of enterobactin biosynthesis along with its partner EntB [28,29]. Additionally, to facilitate crystallization of these proteins, a chimeric protein construct was designed that fused genetically the coding sequences for the EntE adenylation domain with the coding sequence for the carrier protein domain of the bifunctional EntB [29]. Subsequently, a vinylsulfonamide inhibitor was also used to determine the structure of an uncharacterized two domain adenylation-PCP protein from P. aeruginosa [55]. In this latter case, it was first necessary to identify the amino acid substrate preference to design the inhibitor with the appropriate amino acid side chain bound to the vinylsulfonamide linker.

Both the structures of PA1221 and the EntE-B chimeric protein demonstrate that the use of the mechanism-based inhibitor can serve to stabilize the domain interactions sufficiently to allow them to be observed crystallographically. In the case of PA1221, crystallization of the apo-protein in the absence of the inhibitor resulted in a structure in which no electron density could be observed for the carrier protein domain. Interestingly, the adenylation domain adopted the thioester-forming conformation that is identical to that observed to interact with the PCP in the structure of the holo-protein in the presence of the ligand yet still failed to bind the PCP. Thus the inhibitor was a critical reagent for sufficiently stabilizing the interaction to allow the full length protein to be observed in the crystal structure.

9. Conclusions

Despite the multitude of NRPS structures, including the structures of multi-domain proteins over the last five years, there remains much to be done to understand completely the structural basis for NRPS biosynthesis. In particular, more structures are needed of full modules of enzymes that will provide more insights into the nature of the interactions of the NRPS domains. The condensation domain lacks structures in the presence of ligands and more crystal or NMR structures will identify the roles of specific active site residues in binding and catalysis. Additionally, a superposition of the functional interaction between the PCP and thioesterase domains of EntF [60,61] with the SrfA-C structure [45] shows that the PCP domain in the functional interaction is predicted to overlap with the adenylation-condensation core of SrfA-C. This suggests that the thioesterase domain of SrfA-C is not positioned in a “catalytic” orientation in the crystal lattice. Likely, the thioesterase position in SrfA-C is dynamic and adopts a different relative position when it interacts with the PCP in the course of the catalytic cycle. The use of inhibitors such as the α-chloroacetylamide pantetheine derivative [65,61] with full-length EntF, for example, would allow the determination of the PCP-thioesterase interface in the context of a full NRPS module.

Another exciting target of NRPS structural biochemistry is the examination of the additional integrated domains, N-methyltransferases or epimerization domains, in the context of a full NRPS module. The carrier protein domains of SrfA-C, or the E. coli homolog EntF, must make their way to three consecutive catalytic domains (adenylation, condensation, and thioesterase domains). In modules that harbor additional integrated domains, the carrier protein must find its way to yet another catalytic domain and we can ask what structural features are required for these specialized modules.

Additional NRPS structures may also begin to address the question of what dynamic features, within or between catalytic domains, drive the proper delivery of the PCP along the catalytic assembly line. The large rotation of the two sub-domains within the NRPS adenylation domain offers a potential major rearrangement that could facilitate interactions with the PCP. Additional conformational changes may also compel the PCP to bind additional catalytic domains in a proper orientation.

Finally, now that the structure of the complete SrfA-C module [45] has toppled what was once the most sought-after structure in NRPS enzymology, a new high profile target is a structure of a multi-module protein. The SrfA-C structure suggests that the condensation domain and N-terminal subdomain of the adenylation domain form a stable interface and, relative to this platform, the PCP and possibly the other catalytic domains migrate to transit through the catalytic cycle. In a larger, multimodule NRPS, might this platform from one module form a larger complex with the condensation and adenylation domains of the next module as well. While atomic resolution crystal structures would provide answers to these questions, additional structural tools such as electron microscopy and small angle X-ray scattering may also provide insights into the larger macromolecular organization of the catalytic domains.